Clinical Study of Jaktinib in the Treatment of Patients With Moderate and Severe Atopic Dermatitis

NCT04539639 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

166

Enrollment

INDUSTRY

Sponsor class

Conditions

Atopic Dermatitis

Interventions

DRUG: Jaktinib
DRUG: Jaktinib
DRUG: Jaktinib
DRUG: placebo

Sponsor

Suzhou Zelgen Biopharmaceuticals Co.,Ltd